Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.11 is 16% below its 5-year average of 1.32, around the middle of its 5-year range (0.13–2.75).
As of the fiscal period ended Tuesday, June 30, 2026. 39.06% below its 12-month average of 1.82.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.11.
CURRENT RATIO
1.11
CURRENT RATIO AVG TTM
1.82
CURRENT RATIO AVG 3Y
1.48
CURRENT RATIO AVG 5Y
1.32
CURRENT RATIO AVG 10Y
1.08
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-39.06%
CURRENT VS 3Y AVG
-25.08%
CURRENT VS 5Y AVG
-15.68%
CURRENT VS 10Y AVG
+3.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.12
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
-64.42%
vs the sector median at left
Allarity Therapeutics, Inc.
Market Cap
$15.91M
Current Ratio
1.11
TTM Avg
1.82
3Y Avg
1.48
5Y Avg
1.32
Market Cap
$15.30M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
Market Cap
$16.54M
Current Ratio
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$14.28M
Current Ratio
0.84
TTM Avg
0.51
3Y Avg
4.20
5Y Avg
6.42
Market Cap
$13.34M
Current Ratio
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.91M | 1.11 | 1.82 | 1.48 | 1.32 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | 2.09 | 1.13 | 1.21 | 2.30 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 1.24 | 4.22 | 12.60 | 18.98 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | 1.65 | 3.34 | 3.94 | 7.05 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | 2.48 | 1.52 | 2.21 | 4.42 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | 0.84 | 0.51 | 4.20 | 6.42 |
| IN8bio, Inc. (INAB)vs › | $13.62M | 8.21 | 6.45 | 5.32 | 7.60 |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | 4.37 | 1.46 | 1.74 | 1.95 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | 6.66 | 2.77 | 1.93 | 5.53 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.20 | 0.34 | 6.34 | 6.11 |
Current Ratio
1.11
Quick Ratio
1.11
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.11 |
| 2026-03-31 | 1.23 |
| 2025-12-31 | 2.13 |
| 2025-09-30 | 2.33 |
| 2025-06-30 | 2.31 |
| 2025-03-31 | 2.66 |
| 2024-12-31 | 2.06 |
| 2024-09-30 | 2.75 |
| 2024-06-30 | 2.01 |
| 2024-03-31 | 0.13 |
| 2023-12-31 | 0.14 |
| 2023-09-30 | 0.23 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.26 |
| 2022-12-31 | 0.44 |
| 2022-09-30 | 0.47 |
| 2022-06-30 | 0.88 |
| 2022-03-31 | 1.35 |
| 2021-12-31 | 1.03 |
| 2021-09-30 | 1.99 |
| 2021-06-30 | 1.96 |
| 2021-03-31 | 0.35 |
| 2020-12-31 | 0.31 |
| 2020-09-30 | 0.47 |
| 2020-06-30 | 0.52 |
| 2020-03-31 | 0.40 |
| 2019-12-31 | 0.71 |
| 2019-09-30 | 0.29 |
| 2019-06-30 | 0.49 |
| 2019-03-31 | 0.28 |
| 2018-12-31 | 0.41 |
| 2018-09-30 | 0.99 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 1.86 |
| 2017-12-31 | 0.77 |
| 2017-09-30 | 5.15 |
| 2017-06-30 | 6.69 |
| 2017-03-31 | 5.06 |
| 2016-12-31 | 3.27 |
| 2016-09-30 | 5.48 |
| 2016-06-30 | 48.05 |
| 2016-03-31 | 5.78 |
| 2015-12-31 | 5.68 |
| 2015-09-30 | 9.92 |
| 2015-06-30 | 11.60 |
| 2015-03-31 | 100.50 |
